๐ Statistics
- Analyst 1 Year Price Target:
-
- Upside/Downside from Analyst Target:
-
- Broker Call:
-
- Dividend Minimum 3 Year Yield:
0.00%
- EPS Growth Range (1Y):
-
- Net Income Growth Range (1Y):
-
- Revenue Growth Range (1Y):
10-25%
-
Upcoming Earnings Date:
-
๐ฐ Dividend History
๐
SGX Earnings Announcements for FRQ
Singapore Paincare Holdings Limited (FRQ)
Market: SGX |
Currency: SGD
Address: 601 Machperson Road
Singapore Paincare Holdings Limited, an investment holding company, operates medical clinics in Singapore. It offers pain care services for the treatment of patients suffering from acute and chronic pain due to injury, age-related pain conditions, functional pain disorders, post-surgical pain, and cancer pain, including minimally invasive and specialised injections, pharmacotherapy, and cognitive behavioural therapy. The company also offers specialist and surgical care services, which include dermatology, general surgery, orthopaedics, and musculoskeletal and sports medicine services; and associate specialist panel services, comprising cardiology, ENT, neurology, neurosurgery, ophthalmology, urology, and orthopaedic surgeon services. In addition, it provides rehabilitive care and wellness services, which comprise physiotherapy and traditional Chinese medicine; health, executive health, cancer screening services; and corporate healthcare services. Further, the company offers consultancy services for healthcare organisations. It operates five specialist clinics, eleven general practitioner clinics, one traditional Chinese medicine centre, and two physiotherapy centre. The company was founded in 2007 and is based in Singapore.
Show more
๐ Singapore Paincare Holdings Limited Historical Chart
๐งพ Recent Financial Statement Analysis
October 10, 2024
Key Facts from the ReportCompany: Singapore Paincare Holdings LimitedDate of the Report: 10 October 2024Financial Year Ended: 30 June 2024Qualified Opinion: The independent auditors, BDO LLP, issued a qualified opinion due to insufficient audit evidence regarding a 25% stake acquisition…
October 10, 2024
Key Facts:Revenue Growth: Singapore Paincare reported a revenue increase of 21.7%, rising from $22.1 million in FY2023 to $26.9 million in FY2024.Net Profit: The company reversed a net loss of $0.7 million in FY2023 to a net profit of $2.0…
๐ View more in SGX corporate News ๐ View more in SGX Financial statements
๐ฐ Related News & Research
Showing results matched by any of: FRQ.SI, Singapore Paincare Holdings Limited, Sing Paincare, SPCH SP, SINGAPORE PAINCARE HOLDINGS, SINGAPORE PAINCARE
June 6, 2025
Broker: CGS International Date of Report: June 6, 2025 Singapore Paincare Holdings and NIO Inc: Technical Breakouts and Sector Insights โ June 2025 Investment Analysis Market Recap: Global Sentiment and Key Economic Updates Global financial markets saw a notable bounce…
October 10, 2024
Key Facts from the ReportCompany: Singapore Paincare Holdings LimitedDate of the Report: 10 October 2024Financial Year Ended: 30 June 2024Qualified Opinion: The independent auditors, BDO LLP, issued a qualified opinion due to insufficient audit evidence regarding a 25% stake acquisition…
October 10, 2024
Key Facts:Revenue Growth: Singapore Paincare reported a revenue increase of 21.7%, rising from $22.1 million in FY2023 to $26.9 million in FY2024.Net Profit: The company reversed a net loss of $0.7 million in FY2023 to a net profit of $2.0…